0001179110-15-010912.txt : 20150706 0001179110-15-010912.hdr.sgml : 20150703 20150706163221 ACCESSION NUMBER: 0001179110-15-010912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150701 FILED AS OF DATE: 20150706 DATE AS OF CHANGE: 20150706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KUFE DONALD W CENTRAL INDEX KEY: 0001390646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 15973833 MAIL ADDRESS: STREET 1: C/O ADHEREX TECHNOLOGIES INC. STREET 2: 4620 CREEKSTONE DRIVE, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 edgar.xml FORM 4 - X0306 4 2015-07-01 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001390646 KUFE DONALD W C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Director Stock Option (Right to Buy) 2.2 2015-07-01 4 A 0 20000 0 A 2025-07-01 Common Stock 20000 20000 D The option vests as to 25% of the shares on each of September 30, 2015, December 31, 2015, March 31, 2016 and June 30, 2016, provided the Reporting Person continues to serve as a director of the Issuer on such date. /s/ Garrett M. Winslow, Attorney-in-Fact 2015-07-06